Press release
Digital Tornado to Drive the Unstable Angina Therapeutics Market
Anti-angina drugs are the therapeutics used in the treatment of angina pectoris. The condition is the result of myocardial ischemia which occurs due to an imbalance between myocardial blood supply and oxygen requirement. It is the symptom of coronary heart disease in which the arteries carrying blood to the heart become narrow or are blocked due to atherosclerosis.
Several diagnostic tests are performed in order to confirm the condition of angina such as ECG, stress test, echocardiogram, nuclear stress test, chest x-ray, blood tests, coronary angiography, CT scan, cardiac MRI, etc. Anti-angina treatment options include lifestyle changes, medications, angioplasty and stenting, or coronary bypass surgery.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/5837
Segmentations-
By Disease Type
Stable Angina
Unstable Angina
Variant Angina
By Drug Type
Aspirin
Nitrates
Beta Blockers
Statins
Calcium Channel Blockers
Ranolazine
Angiotensin-converting enzyme (ACE) inhibitors
By Dosage Form Type
Oral Dosage Forms
Transdermal
Injectable
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Drug Stores
Mail Order Pharmacies
By Region
North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa
Request For Table of Content@https://www.persistencemarketresearch.com/toc/5837
Nitrates are often used to treat angina as they relax and widen the blood vessels, which allow more blood to flow to the heart muscles. The U.S. FDA has recently approved nitroglycerin sublingual powder "Gonitro" of U.S.-based Espero Pharmaceuticals for acute relief of an angina pectoris attack in 2016.
Beta blockers works by blocking the effects of hormone epinephrine (adrenaline) which causes the heart to beat more slowly and with less force, thus reducing the blood pressure. Combining nitrates with β-blockers is most commonly used to block tachycardia and generating synergetic anti-ischaemic effect.
Oral dosage forms are the most commonly used for the management of angina. This includes normal and extended release tablets & capsules as well as sublingual dosage forms. These drug forms are available as labelled as well as off-labelled medications.
Cardiovascular diseases are the most common cause of deaths globally according to the WHO. Approx. 17.7 million people died from the heart diseases in 2015, representing 31% of all global deaths. High prevalence of ischemic heart disease has been a huge medical and social concern, thus representing a market opportunity for the market players in all the geographies.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/5837
The trends in the development of anti-angina drugs include the use of synergistic combinations, ongoing clinical trials and other pharmacological developments including novel routes of administration, dosing regimen, etc. Further, clinical trials are being done to find out novel compounds for the treatment of angina capable of improving the quality of patients' life and minimizing the cost of healthcare.
The development of new drugs provides additional therapeutic options in the treatment of stable angina. Increasing competition in the generic version of the medicines is a threat for the market players.
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Tornado to Drive the Unstable Angina Therapeutics Market here
News-ID: 2701136 • Views: …
More Releases from Persistence Market Research
Automotive MRO Industry Forecast to Hit US$ 171.3 Billion by 2032, Advancing at …
The global Automotive MRO (Maintenance, Repair, and Operations) market is experiencing steady growth, driven by the increasing need for vehicle maintenance services and aftermarket support across passenger and commercial vehicles. According to Persistence Market Research, the market is expected to reach a value of US$171.3 Bn by 2032, up from US$126.7 Bn in 2025, reflecting a CAGR of 4.4% during the forecast period of 2025 to 2032. The market growth…
Global Automotive Horn Industry Forecast at US$3.3 Billion by 2032, Led by Compa …
The automotive horn market plays a crucial yet often understated role in the global automotive ecosystem, serving as a primary safety and communication component across vehicle categories. Automotive horns are mandated safety devices designed to alert pedestrians, cyclists, and other vehicles, thereby reducing the risk of collisions in diverse traffic environments. As global vehicle production and on-road vehicle density continue to rise, the relevance of reliable and effective horn systems…
Aircraft Flight Control System Market to Hit US$ 45.7 Billion by 2033 as Key Pla …
The Aircraft Flight Control System Market represents a critical pillar of the global aerospace and aviation ecosystem, enabling safe, efficient, and precise aircraft operations across commercial, military, and general aviation platforms. Flight control systems are responsible for managing aircraft stability, maneuverability, and responsiveness by translating pilot or automated inputs into aerodynamic actions. As aviation technology continues to evolve, these systems have transformed from purely mechanical assemblies into highly integrated digital…
U.S. & Canada Bicycle Accessories Market to Hit US$3.7 Billion by 2033 as Key Pl …
The U.S. & Canada bicycle accessories market is undergoing a notable transformation as cycling continues to gain traction as a preferred mode of transportation, fitness activity, and recreational pursuit. Changing urban mobility patterns, increasing focus on personal health, and a growing emphasis on eco-friendly transportation are reshaping the demand landscape for bicycle accessories across North America. From safety gear and lighting systems to advanced smart accessories, the market is evolving…
More Releases for Angina
Angina Market Key Players, Trends & Forecast to 2034
The Angina Market is experiencing steady growth worldwide as heart disease cases rise and healthcare providers adopt advanced diagnostic tools, novel anti-anginal medications, and cutting-edge interventional cardiology treatments. With precision diagnostics, long-acting drug therapies, and improved cardiac revascularization techniques, the market is set for substantial expansion through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/52004
1. What Is Angina? (Keyword Definition)
Angina pectoris-commonly known as angina-is chest pain or discomfort caused…
Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pecto …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rate…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
